Literature DB >> 17717147

Secreted protein acidic and rich in cysteine deficiency ameliorates renal inflammation and fibrosis in angiotensin hypertension.

Matthew J Socha1, Marlina Manhiani, Neveen Said, John D Imig, Kouros Motamed.   

Abstract

The matricellular protein secreted protein acidic and rich in cysteine (SPARC) modulates cell adhesion, proliferation, matrix deposition, and tissue remodeling. SPARC has been shown to regulate the expression of collagen type I and transforming growth factor-beta1 in mesangial cells and to be highly expressed during tubulointerstitial fibrosis in rat angiotensin (ANG) II infusion models. We hypothesized that SPARC is a downstream effector of ANG II and that loss of host SPARC function provides a protective effect on renal damage and fibrosis associated with ANG II hypertension. Our results revealed that cultured primary mesangial cells displayed a concentration-dependent increase in SPARC expression in response to ANG II. After a 14-day chronic infusion of ANG II, hypertensive SPARC-null mice exhibited significantly attenuated levels of urinary and renal indicators of oxidative stress and inflammation and decreased renal perivascular and tubulointerstitial fibrosis relative to wild-type hypertensive controls. Moreover, the observed renal protective changes in SPARC-null mice were found to be independent of blood pressure. These results identify SPARC as an effector of ANG II signaling and suggest an important role for SPARC in mediating ANG II-induced oxidative stress, inflammation, and fibrosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17717147      PMCID: PMC1988862          DOI: 10.2353/ajpath.2007.061273

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  38 in total

1.  Induction of TGF-beta1 by the matricellular protein SPARC in a rat model of glomerulonephritis.

Authors:  J A Bassuk; R Pichler; J D Rothmier; J Pippen; K Gordon; R L Meek; A D Bradshaw; D Lombardi; T P Strandjord; M Reed; E H Sage; W G Couser; R Johnson
Journal:  Kidney Int       Date:  2000-01       Impact factor: 10.612

2.  SPARC regulates the expression of collagen type I and transforming growth factor-beta1 in mesangial cells.

Authors:  A Francki; A D Bradshaw; J A Bassuk; C C Howe; W G Couser; E H Sage
Journal:  J Biol Chem       Date:  1999-11-05       Impact factor: 5.157

Review 3.  The biology of SPARC, a protein that modulates cell-matrix interactions.

Authors:  T F Lane; E H Sage
Journal:  FASEB J       Date:  1994-02       Impact factor: 5.191

4.  Renal injury from angiotensin II-mediated hypertension.

Authors:  R J Johnson; C E Alpers; A Yoshimura; D Lombardi; P Pritzl; J Floege; S M Schwartz
Journal:  Hypertension       Date:  1992-05       Impact factor: 10.190

Review 5.  Vascular inflammation: a role in vascular disease in hypertension?

Authors:  Agostino Virdis; Ernesto L Schiffrin
Journal:  Curr Opin Nephrol Hypertens       Date:  2003-03       Impact factor: 2.894

6.  Generation of reactive oxygen species by the mitochondrial electron transport chain.

Authors:  Yuanbin Liu; Gary Fiskum; David Schubert
Journal:  J Neurochem       Date:  2002-03       Impact factor: 5.372

7.  Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-kappa B activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis.

Authors:  M Hernández-Presa; C Bustos; M Ortego; J Tuñon; G Renedo; M Ruiz-Ortega; J Egido
Journal:  Circulation       Date:  1997-03-18       Impact factor: 29.690

Review 8.  Reactive oxygen species in vascular biology: implications in hypertension.

Authors:  R M Touyz; E L Schiffrin
Journal:  Histochem Cell Biol       Date:  2004-08-26       Impact factor: 4.304

9.  SPARC regulates cell cycle progression in mesangial cells via its inhibition of IGF-dependent signaling.

Authors:  Aleksandar Francki; Kouros Motamed; Timothy D McClure; Marcus Kaya; Carrie Murri; David J Blake; Juliet G Carbon; E Helene Sage
Journal:  J Cell Biochem       Date:  2003-03-01       Impact factor: 4.429

10.  Markers of complement-dependent and complement-independent glomerular visceral epithelial cell injury in vivo. Expression of antiadhesive proteins and cytoskeletal changes.

Authors:  J Floege; C E Alpers; E H Sage; P Pritzl; K Gordon; R J Johnson; W G Couser
Journal:  Lab Invest       Date:  1992-10       Impact factor: 5.662

View more
  28 in total

1.  Secreted protein acidic and rich in cysteine facilitates age-related cardiac inflammation and macrophage M1 polarization.

Authors:  Hiroe Toba; Lisandra E de Castro Brás; Catalin F Baicu; Michael R Zile; Merry L Lindsey; Amy D Bradshaw
Journal:  Am J Physiol Cell Physiol       Date:  2015-04-15       Impact factor: 4.249

Review 2.  Matricellular proteins in cardiac adaptation and disease.

Authors:  Nikolaos G Frangogiannis
Journal:  Physiol Rev       Date:  2012-04       Impact factor: 37.312

3.  Loss of SPARC in bladder cancer enhances carcinogenesis and progression.

Authors:  Neveen Said; Henry F Frierson; Marta Sanchez-Carbayo; Rolf A Brekken; Dan Theodorescu
Journal:  J Clin Invest       Date:  2013-01-16       Impact factor: 14.808

Review 4.  Extracellular matrix roles in cardiorenal fibrosis: Potential therapeutic targets for CVD and CKD in the elderly.

Authors:  Hiroe Toba; Merry L Lindsey
Journal:  Pharmacol Ther       Date:  2018-08-25       Impact factor: 12.310

5.  Attenuation of fibrosis in vitro and in vivo with SPARC siRNA.

Authors:  Jiu-Cun Wang; Syeling Lai; Xinjian Guo; Xuefeng Zhang; Benoit de Crombrugghe; Sonali Sonnylal; Frank C Arnett; Xiaodong Zhou
Journal:  Arthritis Res Ther       Date:  2010-04-01       Impact factor: 5.156

6.  Serum SPARC and matrix metalloproteinase-2 and metalloproteinase-9 concentrations after bariatric surgery in obese adults.

Authors:  Yeon Ji Lee; Yoon-Seok Heo; Hye Soon Park; Seoung Hee Lee; Seul Ki Lee; Yeon Jin Jang
Journal:  Obes Surg       Date:  2014-04       Impact factor: 4.129

Review 7.  Cardiac extracellular matrix remodeling: fibrillar collagens and Secreted Protein Acidic and Rich in Cysteine (SPARC).

Authors:  Sarah McCurdy; Catalin F Baicu; Stephane Heymans; Amy D Bradshaw
Journal:  J Mol Cell Cardiol       Date:  2009-07-03       Impact factor: 5.000

8.  Differential effects of 17beta-estradiol and of synthetic progestins on aldosterone-salt-induced kidney disease.

Authors:  Paula-Anahi Arias-Loza; Melanie Muehlfelder; Susan A Elmore; Robert Maronpot; Kai Hu; Hartmut Blode; Christa Hegele-Hartung; Karl Heinrich Fritzemeier; Georg Ertl; Theo Pelzer
Journal:  Toxicol Pathol       Date:  2009-12       Impact factor: 1.902

9.  Regulation of the fibrosis and angiogenesis promoter SPARC/osteonectin in human adipose tissue by weight change, leptin, insulin, and glucose.

Authors:  Katrina Kos; Steve Wong; Bee Tan; Anders Gummesson; Margareta Jernas; Niclas Franck; David Kerrigan; Fredrik H Nystrom; Lena M S Carlsson; Harpal S Randeva; Jonathan H Pinkney; John P H Wilding
Journal:  Diabetes       Date:  2009-06-09       Impact factor: 9.461

10.  The role of SPARC in extracellular matrix assembly.

Authors:  Amy D Bradshaw
Journal:  J Cell Commun Signal       Date:  2009-10-02       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.